Glenmark Pharma stock plummets 4

Shares of Glenmark Pharmaceuticals were lower on reports over the weekend that the company has lost a patent case against U.S. firm Abbott Laboratories over hypertension drug Tarka.

Subsequently,it will pay 16 million in damages to the U.S. firm,two dealers said.

At 9.25 a.m.,shares of the company were down 4.13 percent at 333.50 rupees.